Moberg Pharma Correlations
| MOB Stock | SEK 8.80 0.11 1.23% |
The current 90-days correlation between Moberg Pharma AB and Mendus AB is 0.22 (i.e., Modest diversification). The correlation of Moberg Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Moberg Pharma Correlation With Market
Good diversification
The correlation between Moberg Pharma AB and DJI is -0.15 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Moberg Pharma AB and DJI in the same portfolio, assuming nothing else is changed.
Moberg |
The ability to find closely correlated positions to Moberg Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Moberg Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Moberg Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Moberg Pharma AB to buy it.
Moving together with Moberg Stock
| 0.72 | CLAV | Clavister Holding | PairCorr |
| 0.72 | SHOT | Scandic Hotels Group | PairCorr |
| 0.65 | RATO-B | Ratos AB | PairCorr |
| 0.71 | RESURS | Resurs Holding AB | PairCorr |
| 0.72 | FG | Fasadgruppen Group | PairCorr |
| 0.71 | NTEK-B | Novotek AB | PairCorr |
| 0.83 | SINT | SinterCast AB | PairCorr |
| 0.68 | BINV | BioInvent International | PairCorr |
| 0.74 | SKF-A | AB SKF | PairCorr |
| 0.68 | SWED-A | Swedbank AB | PairCorr |
| 0.64 | QLINEA | Q linea AB Split | PairCorr |
| 0.64 | SVED-B | Svedbergs i Dalstorp | PairCorr |
| 0.84 | ACCON | Acconeer AB | PairCorr |
| 0.73 | ASKER | Asker Healthcare Earnings Call This Week | PairCorr |
| 0.73 | UTG | Unlimited Travel | PairCorr |
| 0.85 | PCAT | Photocat AS | PairCorr |
Moving against Moberg Stock
| 0.76 | EWRK | eWork Group AB | PairCorr |
| 0.59 | NJOB | NetJobs Group AB | PairCorr |
| 0.58 | REALFI | Realfiction Holding | PairCorr |
| 0.57 | ENZY | Enzymatica publ AB Earnings Call Next Week | PairCorr |
Related Correlations Analysis
| 0.52 | 0.83 | 0.22 | 0.76 | IMMU | ||
| 0.52 | 0.71 | 0.08 | 0.77 | BINV | ||
| 0.83 | 0.71 | 0.1 | 0.82 | ORX | ||
| 0.22 | 0.08 | 0.1 | -0.04 | ONCO | ||
| 0.76 | 0.77 | 0.82 | -0.04 | SANION | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Moberg Stock performing well and Moberg Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Moberg Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IMMU | 4.79 | 0.99 | 0.16 | (0.90) | 4.20 | 15.12 | 34.83 | |||
| BINV | 2.80 | 0.36 | 0.09 | 0.40 | 3.71 | 6.05 | 23.77 | |||
| ORX | 2.44 | 0.57 | 0.13 | (0.61) | 2.25 | 6.92 | 18.98 | |||
| ONCO | 4.59 | 1.16 | 0.19 | 5.12 | 4.34 | 14.19 | 64.45 | |||
| SANION | 3.33 | 0.37 | 0.10 | 0.50 | 3.61 | 11.04 | 40.36 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Moberg Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Moberg Pharma Corporate Management
Elected by the shareholders, the Moberg Pharma's board of directors comprises two types of representatives: Moberg Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Moberg. The board's role is to monitor Moberg Pharma's management team and ensure that shareholders' interests are well served. Moberg Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Moberg Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Beveridge | VP Fin | Profile | |
| Anders Broijersen | Chief Officer | Profile | |
| MSc BA | Chief Officer | Profile | |
| Kerstin Strinnholm | Ex Chairman | Profile | |
| Marie Moberg | CoFounder | Profile | |
| Gunilla Wengstrm | Director Marketing | Profile |